SnapShot: Cancer Immunotherapy with Oncolytic Viruses

Shashi Gujar, John Bell, Jean Simon Diallo

Résultat de recherche: Short surveyexamen par les pairs

70 Citations (Scopus)

Résumé

Oncolytic viruses (OVs) preferentially infect and kill cancer cells without harming normal cells. OVs can revert cancer-associated immune suppression and initiate clinically meaningful antitumor immune responses. OVs and their resultant immunological events can act at both primary and metastatic sites. Thus, OVs can be exploited for cancer gene therapies and immunotherapies alone or in combination with other interventions, including immune checkpoint blockade.

Langue d'origineEnglish
Pages (de-à)1240-1240.e1
JournalCell
Volume176
Numéro de publication5
DOI
Statut de publicationPublished - févr. 21 2019

Note bibliographique

Publisher Copyright:
© 2019

ASJC Scopus Subject Areas

  • General Biochemistry,Genetics and Molecular Biology

Empreinte numérique

Plonger dans les sujets de recherche 'SnapShot: Cancer Immunotherapy with Oncolytic Viruses'. Ensemble, ils forment une empreinte numérique unique.

Citer